Portfolio comparison
Dexcom vs University of Pennsylvania Penn
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Dexcom
Patents indexed
3
Year range
2016 – 2022
Most recent
2022
How Glucose Sensors Check Their Own Reliability for Insulin Pumps
A Catheter That Measures Glucose While Delivering Medication
How a Sensor Checks Itself for Accuracy Using Other Body Data
Activity by Decade
Company B
University of Pennsylvania Penn
Patents indexed
4
Year range
2012 – 2024
Most recent
2024
How Modified RNA Tricks Cells Into Making Proteins Without Triggering Attacks
How Genetically Modified T-Cells Fight CD19 Cancers
How Genetically Modified T-Cells Attack Cancer
Activity by Decade
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.